COCO insider Michael Kirban discloses 10b5-1 sales at $45.701, $44.211
Rhea-AI Filing Summary
Vita Coco (COCO) Executive Chairman and Director Michael Kirban reported open‑market sales made under a Rule 10b5‑1 trading plan. He sold 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average price of $44.211 on 10/30/2025.
The 10/30 transactions occurred in multiple trades between $44.00 and $45.00. Following the reported sales, beneficial ownership reported included 1,484,151 shares held indirectly by the Michael Kirban 2010 Trust, plus 127,629 shares held directly and 615,681 shares held indirectly by the Michael Kirban Revocable Trust.
Reported derivative holdings include non‑qualified stock options to purchase 546,000 shares at $10.178 expiring 12/16/2029 (fully vested), 298,507 shares at $15 expiring 10/21/2031, and 70,715 shares at $32.78 expiring 03/03/2035, among others, with specified vesting schedules.
Positive
- None.
Negative
- None.
Insights
Routine insider sales under a 10b5‑1 plan; neutral impact.
Michael Kirban, Executive Chairman of Vita Coco, disclosed sales of 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average $44.211 on 10/30/2025, executed pursuant to a Rule 10b5‑1 plan. The 10/30 trades spanned $44.00–$45.00.
Post‑transaction, the filing lists 1,484,151 shares indirectly via the 2010 Trust, plus 127,629 direct and 615,681 via the Revocable Trust. Derivative positions include options such as 546,000 at $10.178 expiring 12/16/2029 and 298,507 at $15 expiring 10/21/2031.
These are administrative disclosures typical for Form 4. Actual market impact depends on holder activity and trading volumes; the presence of a 10b5‑1 plan indicates pre‑established trading instructions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 14,898 | $44.211 | $659K |
| Sale | Common Stock | 30,000 | $45.701 | $1.37M |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. These shares are held by the Michael Kirban 2010 Trust. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $45.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Michael Kirban Revocable Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
